Carson Wealth (CWM LLC)
NMRA icon

Carson Wealth (CWM LLC)’s Neumora Therapeutics NMRA Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.13K Sell
3,146
-2,031
-39% -$5.26K ﹤0.01% 4955
2025
Q4 		$9K Sell
5,177
-5,959
-54% -$13K ﹤0.01% 4604
2025
Q3 		$20K Sell
11,136
-24,614
-69% -$39.8K ﹤0.01% 4126
2025
Q2 		$26K Buy
35,750
+10,537
+42% +$7.98K ﹤0.01% 3745
2025
Q1 		$25K Buy
25,213
+24,864
+7,124% +$42.6K ﹤0.01% 3517
2024
Q4 		$4K Buy
349
+187
+115% +$2.24K ﹤0.01% 4337
2024
Q3 		$2K Buy
162
+68
+72% +$793 ﹤0.01% 4435
2024
Q2 		$1K Buy
94
+91
+3,033% +$942 ﹤0.01% 4433
2024
Q1 		$0 Buy
+3
New +$49 ﹤0.01% 4595

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return

Carson Wealth (CWM LLC)'s NMRA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Neumora Therapeutics (NMRA) stake by 39% in Q1 2026, selling an estimated $5.26K and leaving 3,146 shares worth $6.13K. The position accounts for ﹤0.01% of the portfolio, ranked #4955.

Carson Wealth (CWM LLC) first reported a position in NMRA in Q1 2024 and has held it in 9 quarters since. The position peaked at $26K in Q2 2025. 114 funds tracked by Wall St. Rank hold NMRA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 3,146 shares of Neumora Therapeutics worth $6.13K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 2,031 Neumora Therapeutics shares in Q1 2026, an estimated $5.26K.
  • Neumora Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4955 holding.
  • Carson Wealth (CWM LLC) first reported a position in Neumora Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Carson Wealth (CWM LLC)'s Neumora Therapeutics position peaked at $26K in Q2 2025.
  • 114 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.